Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cholesterol/Lipid Disorders
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cholesterol/Lipid Disorders
    TopAbstracts in Cholesterol/Lipid Disorders 11/26/2009 - (DGNews)
    Statins Can Reduce Risk of Major Cardiovascular Events in Healthy Women: Presented at AHA - (DGDispatch)
    Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006 - (JAMA)
    Atorvastatin Improves Renal Function in Patients With Heart Disease, Metabolic Syndrome: Presented at AHA - (DGDispatch)
    Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness - (N Engl J Med)

    News archive

     Recent webcasts/CME - Cholesterol/Lipid Disorders
      Medication Use for Diabetes, Hypertension, and Hypercholesterolemia from 1988-1994 to 2001-2006
      Diabetes and the Heart: Cardiac Care for the Patient with Diabetes: Clinical Horizons
      High-Density Lipoprotein and the Epidemiology of Coronary Heart Disease
      Diabetes Management - Pearls of Lipid Control
      Initiating and Monitoring Statin Therapy

      Webcasts/CME archive

       Recent cases - Cholesterol/Lipid Disorders
        Lipemic Serum In Hyperlipidemic Pancreatitis
        There May be a Link Between Intrahepatic Cholestasis of Pregnancy and Familial Combined Hyperlipidaemia: A Case Report
        Marked Aortic Valve Stenosis Progression After Receiving Long-Term Aggressive Cholesterol-Lowering Therapy Using Low-Density Lipoprotein Apheresis in a Patient With Familial Hypercholesterolemia
        Acute Myocardial Infarction in an 18 Year Old South Indian Girl with Familial Hypercholesterolemia: A Case Report
        Eruptive Xanthomas and Acute Pancreatitis in a Patient with Hypertriglyceridemia

        Cases archive
          




        my personal edition > cholesterol/lipid disorders > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Recurrence of Atrial Fibrillation Reduced With Alpha-Linolenic Acid-Enriched Diet: Presented at DALM

        By Crina Frincu-Mallos, PhD

        NEW YORK, NY -- October 17, 2007 -- Alpha-linolenic acid (ALA) may reduce the recurrence of atrial fibrillation, according to researchers reporting at the XVI International Symposium on Drugs Affecting Lipid Metabolism (DALM).

        Dominique Lanzmann-Petithory, MD, PhD, Physician Practitioner in Public Health, Department of Geriatric Medicine, Emile Roux Hospital, Paris, France, and colleagues randomised a total of 111 patients in a controlled efficacy study. Fifty-three patients were started on an ALA-rich diet in which they were instructed to replace any other fats and oils with canola margarine and canola oil (1.4 g/day ALA omega 3 fatty acid). Forty-five patients continued to eat their usual diet.

        Fasting blood samples and 24-hour dietary recalls were collected at enrollment, and at 2, 6 and 12 months, or until the recurrence of atrial fibrillation.

        Data from 40 patients in the ALA group (mean BMI 28+- 4.7 kg/m2) and 35 control patients (mean BMI 27.4+- 4.1 kg/m2) demonstrate that the shorter chain omega-3 vegetable fatty-acid ALA may reduce the recurrence of atrial fibrillation, noted Dr. Lanzmann-Petithory.

        The Kaplan-Meier Survival curves for atrial-fibrillation recurrence during the year demonstrated that recurrence was significantly less prone to occur in patients on the ALA treatment (OR 2.15, P =.037). The survival rate was 25.52% in the control group versus 63.09% in the ALA group at the end of the 12-month period.

        "The present preliminary study provides support for further exploration of the use of ALA in the reduction of cardiovascular risk," said the researchers.

        Since the levels of ALA intake in Western populations are much lower than the advised 1.5 g/day (for men) and 1.3 g/day (for women), these results are particularly relevant for this patient population, the researchers concluded.

        Cardiac arrhythmia and ventricular fibrillation are usually responsible for sudden cardiac death following an infarction, and the prevention of life-threatening arrhythmic events is a problem researchers have already started to tackle using a nutritional approach -- especially after the Lyon Diet Heart Study demonstrated that ALA reduced fatal and non-fatal cardiac events.

        This study took place at three university hospital centers in the Bordeaux region of France.


        [Presentation title: Prevention of Atrial Fibrillation Recurrence With an alpha-Linolenic Acid-Enriched Diet: A Randomized Study. Abstract 439]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send